Exemplary embodiments of the present invention relate to a detection system and a method for its production and more particularly to the detection of (bio) molecules (analytes, ligands, etc.) in abiotic and biotic systems.
Despite enormous biomedical research efforts, cancer still has high mortality rates. In addition, each type of cancer represents a therapeutic and diagnostic challenge for the treating physician. Unfortunately, reliable predictions of the extent to which the course of a disease will develop in the context of the therapeutic measures used are still fraught with high error rates. In this context, early diagnostic measurement methods are of great importance.
For example, prostate cancer (PCa) is the most common cancer in men in the Western world. In Germany alone, around 63,000 new cases are diagnosed each year. Fast on-site diagnostics that precisely produce a meaningful result should significantly increase the chances of a cure for PCa patients and, in many cases, be life-saving. The concentration of the prostate-specific antigen (PSA) can be measured for the early detection of PCa. This is a glycosylated protein that can be detected in the blood serum. In routine operation, the detection of PSA primarily uses antibody-based detection methods, which in addition to high costs often also produce false positive results. This fact is the starting point for the search for alternative measurement methods for the detection of PSA.
One approach is based on nucleic acid biopolymers such as aptamers, which are able to specifically recognize PSA and bind with high affinity. They can be used in a handy sensor system to measure the PSA concentration in the blood and thus to detect a possible prostate carcinoma. If such aptamers are fixed to the inner wall of nanoscale pores/channels of a filter film, a simple sensor for PSA detection can be produced.
An example of this type of detection can be found in the publication: Ali M, Nasir S, Ensinger W.: “Bioconjugation-induced ionic current rectification in aptamer-modified single cylindrical Pores”; Chem Commun 2015, 51: 3454-3459. A potential difference is created between both sides of a plastic film in order to generate a measurable ion current. If the blood serum contains the biomolecules to be detected, these molecules are bound to the aptamers in the pores, which leads to a narrowing of the cross-sectional area of the pores. This increases the electrical resistance of the individual pores depending on the concentration of the aptamer complexes. Consequently, the concentration of the biomolecule can be directly deduced from the decrease in the measured ion current.
In the production of these sensors, the aptamers used are applied to a multipore film, particularly in the area of the pores. This step is referred to as functionalization, since the resulting film is thereby predetermined for a specific function (detection of a biomolecule). In the production method used to date, the film was first functionalized, then cut back and finally arranged in a desired detection area. This so-called “pick-and-place” process is complex and can only be automated to a limited extent. Functionalized membranes can be damaged during the integration process (installation) and thus lose their functionality again. The functionalization of the etched membrane after its integration therefore offers advantages.
There is therefore a need for an improved production process for these sensors. There is also a need for improved aptamers that are highly sensitive to PSA and thus significantly improve the results.
Exemplary embodiments of the present invention relate to a method for producing a detection system for biomolecules in a medium. The method comprises the following steps:
wherein along the flow path through the membranes, bioreceptors are formed on the membrane (for example in the pore area) in order to be able to determine a concentration of the biomolecules in the medium by measuring the flow along the flow paths.
The term “biomolecule” is to be interpreted broadly within the scope of the present invention and in particular encompass ligands, analytes, etc. The medium used can be any body fluid (especially blood). The system can also be used for water analysis, the food industry, pharmaceutical industry, etc. to detect certain substances. The membrane can be formed in one or more parts, so that the term “membrane” should also encompass various membranes. Likewise, the term “pore” should be interpreted broadly and refer to any opening or channel, as long as the opening/channel allows flow. In particular, the pore should not be restricted to a specific aspect ratio (length-to-diameter).
Optionally, the arrangement step comprises: Placing the membrane on the first detector section or on the second detector section; and then removing a portion of the membrane outside a detection area. For example, the membrane can first be applied over the entire area to one of the detector sections and then structured (for example cut to size) such that it is arranged only in one detection area between the first channel area and the second channel area.
Optionally, the method further comprises forming an adhesive layer that is in contact with the membrane. The adhesive layer can be brought into contact with the membrane in such a way that at least some of the pores are closed by the adhesive layer, in order to thereby increase the sensitivity of the membrane by reducing the number of pores for the flow measurement of the medium. For example, the adhesive layer can be used to selectively close (seal) some pores.
Optionally, the method further comprises attaching the bioreceptors to the membrane by means of a functionalization, the functionalization being carried out before or after the arrangement of the first detector section and the second detector section on opposite sides of the membrane. It goes without saying that the attachment should also include coupling and/or binding of the receptors. The functionalization can include, for example, at least the following functionalization steps: Activating a carboxy end group to obtain an amine-reactive intermediate; and amidizing the amine-reactive intermediate to form desired bioreceptors on the membrane.
The functionalization can take place in the same way in all regions of the membrane. However, it is also possible for different bioreceptors to be formed (or coupled or bound) in the pores during functionalization in different areas of the membrane, so that the membrane becomes sensitive to different biomolecules in different areas. In addition, the various functionalization steps can be carried out on a single membrane. However, it is also possible that the membrane has several parts or that several membranes are used for detection, which are to be functionalized differently.
Optionally, the method further comprises laminating the membrane to the first detector section and/or to the second detector section.
The first detector section and the second detector section can be connected to each another on the opposite sides of the membrane by a thermal treatment at a temperature of at least 50° C. or at least 65° C. Adequate impermeability can be achieved in this way. It is also possible to obtain an impermeable connection without a temperature treatment, for example by gluing.
Optionally, the concentration of the biomolecules in the medium can be determined by at least one of the following measurements: (i) a flow measurement through the at least one pore, (ii) an impedance measurement, and (iii) an electrokinetic measurement, in particular an electrophoresis or an electroosmosis measurement. In the simplest case, an electrical resistance measurement can be carried out which is proportional to the flow of the medium through the pore. In this way, a current strength and thus the number of charge carriers (i.e. ions in the medium) can be measured that pass through the pore per unit of time.
Optionally, the biomolecules include a prostate-specific antigen (PSA) and the bioreceptors aptamers. The aptamers used can in particular be one of the following aptamers:
The present invention also relates to a detection system for biomolecules in a medium. The detection system comprises the following: a first channel area and a second channel area, into which the medium can be introduced, and a membrane which has at least one pore and separates the first channel region from the second channel region. In addition, a first electrode and a second electrode are formed along a flow direction of the medium on opposite sides of the membrane. Bioreceptors are formed or coupled or connected to or in the pore and comprise at least one of the following aptamers:
A PSA concentration in the medium can thus be measured via a resistance measurement along a flow path for the medium between the first electrode and the second electrode. In the simplest case, an electrical resistance of an electrolytic flow can be measured (by applying a voltage between the electrodes).
The at least one pore in the membrane can have a tapered or a cylindrical profile along the flow path.
Optionally, the membrane includes different receptors or different aptamers in different areas to enable simultaneous detection of different biomolecules.
Optionally, the first channel region and/or the second channel region perpendicular to the flow path has a maximum channel width of 50 microns or at most 10 microns. This makes it possible to effectively achieve a single-pore membrane by wetting the membrane (for example, if the pore density in the membrane is selected accordingly), which increases the sensitivity. The channel width can also be up to 1 mm. A lower limit is typically 1 micron for the materials used, but it could become lower if silicon or other materials are used.
Optionally, the detection system further comprises an electrolyte inlet at the second electrode and an analyte inlet at the first electrode in order to be able to introduce the medium in the analyte inlet and an electrolyte into the electrolyte inlet. As a result, an amount of the medium required for the detection can be reduced.
The present invention also relates to a use or a method for using one of the detection systems described for the detection of biomolecules in a medium, the detection being carried out by measuring an electrical variable which depends on an electrical resistance between the electrode and the second electrode.
Exemplary embodiments thus relate in particular to an electrochemical sensor for the detection of biotic and abiotic ligands (biomolecules). These include any molecular, organic and inorganic compound of any kind, environmental toxins, agricultural chemicals, hormones, proteins, antibiotics, neurotoxins. This also includes bacteria, viruses and parasites, which can be part of organism groups.
An advantage of exemplary embodiments lies in the fact that a cost-effective alternative to the prior art can thereby be achieved which has a higher selectivity and sensitivity. The invention further enables the integration of nanosensors in a microfluidic system which can be used as a portable mobile analyzer system for various applications, such as those mentioned above. Because of the wide range of possible uses of the exemplary embodiments, the present invention can also be used, in particular, for applications which have hitherto not been able to be analyzed, or which have only been able to be analyzed in a very complex manner.
In addition, the functionalization has a high selectivity, so that only the PSA is coupled/connected to the pore.
In particular, exemplary embodiments make it possible to significantly simplify and thus facilitate early diagnosis of prostate cancer (PCa).
The exemplary embodiments of the present invention will be better understood from the following detailed description and the accompanying drawings of the different embodiments, which should not be construed as limiting the disclosure to the specific exemplary embodiments but are for explanation and understanding only.
Providing S110 a first detector section having a first channel region and a second detector section having a second channel region;
Providing S120 a membrane having at least one pore; and
Arranging S130 the first detector section and the second detector section on opposite sides of the membrane, such that at least part of the first channel region and the second channel region are separated by the membrane and the first channel region and the second channel region are connected to each another to form a channel system to form a flow path for the medium through the at least one pore of the membrane.
It is understood that this list does not imply any order. The production steps mentioned can be carried out independently of one another or in parallel. The membrane bioreceptors are formed on the membrane along the flow path in order to determine a concentration of the biomolecules in the medium by measuring the flow (for example the resistance) along the flow path.
A cross-sectional view through the pore 110 is shown on the left-hand side of
The detection system comprises in detail a first channel region 215 and a second channel region 225 with the membrane 120 arranged between them (see
The medium 50 contains ions (for example as part of the electrolyte) and the biomolecules 114 to be detected, which can also be ions (but need not be). There is also a first electrode 315 in the first channel region of 215 and a second electrode 325 in the second channel region 225. By applying the voltage U between the first electrode 315 and the second electrode 325, a current I flows through the nanochannel 110 (see
The change in electrical resistance can be determined by measuring the current voltage. The corresponding characteristic is shown in
As mentioned at the beginning, a corresponding functionalization of the membrane is required, in which corresponding bioreceptors 112 are attached within the pore 110, so that the membrane is highly sensitive to certain molecules to be detected. The pore(s) themselves can also be created during the functionalization.
The surface properties can be adjusted by covalent linkage with different receptor molecules 112, such as nucleic acid aptamers (DNA/RNA). According to Ali et al. (Ali M, Nasir S, Ensinger W. 2015. Bioconjugation-induced ionic current rectification in aptamer-modified single cylindrical nanopores. Chem Commun 51: 3454-3459) the coupling can be carried out in a two-step reaction using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and sulfo-NHS (N-hydroxysulfosuccinimide). The reaction mechanism of linking a biological receptor 112 (e.g. an aptamer) with carboxylic acid/carboxylate groups located on the surface by EDC/NHS coupling chemistry can be realized as follows:
According to exemplary embodiments of the present invention, the reaction takes place in the microfluidic system, the construction and production of which is explained in more detail below.
First step (activation): Here the carboxy end groups are activated by the esterification of NHS using EDC. An O-acylated urea intermediate is initially formed, which is converted into an amine-reactive NHS ester. For this purpose, the membrane 120 is integrated into the microfluidic system. The system is then filled with a freshly prepared aqueous solution (pH 7) of 0.2 mM EDC and 0.4 mM NHS. The activation of the surface of the pores 110 is completed after one hour.
Second step (amidization): This is where the functionalization takes place with the receptor molecules 112 (aptamers), the chemical structure of which contains at least one primary amino group (—NH2). This amino group reacts with the activated carboxylic acid ester at room temperature to form an amide bond (—(C═O)—NH—). For this purpose, the microfluidic system is filled with a 0.1 mM aqueous solution of the receptor molecule 112 (aptamer) and left to stand overnight.
Successful functionalization is verified by measuring a current-voltage characteristic, since unfunctionalized and functionalized pores 110 differ at the same potential by different current strengths. This sensory principle has already been explained with
The following molecules are to be used as PSA-specific aptamers as bioreceptors 112:
The sensory properties of the functionalized (single-pore) plastic films 120 can be examined in a macro cell. For this purpose, the exemplary single-pore plastic films 120 can be used, which are manually clamped between two liquid chambers 215, 225 before each examination. The advantageous single-pore plastic films 120 are difficult to produce. In contrast, multipore plastic films can be mass-produced. However, they have a lower sensitivity compared to the individual pores.
In order to combine the advantages of both films, the wetting area of the multipore film 120 is reduced to such an extent that a single pore is still in contact with the liquid. This takes place through integration into a microsystem and thus enables the use of the detection system by untrained users.
In the microfluidic system of
The second detector region 500B is shown enlarged on the right-hand side of
The membrane 120 is designed, for example, horizontally and the analyte flow from one of the analyte inlets 530 takes place, for example, in the vertical direction through the membrane 120 to the channel 521, which leads to the electrolyte inlet 520. This flow can be generated either vertically downwards or vertically upwards by an applied voltage to the corresponding electrodes. The mode of operation of the detection system is illustrated further below by the representation of the production. Since there are several analyte inlets 530, different measurements can be carried out in parallel or in succession (for example for different biomolecules 114). In this way, the different analyte inlets 530 can be led to different regions of the membrane 120, which are functionalized differently, so as to allow an analysis for different biomolecules 114 in parallel.
The electrode structure produced in this way can also be seen in
In
In the production step from
In the subsequent production step from
The result is shown in the spatial representation in
In
In the following step (see
If the membrane 120 is applied over the entire area to the structures of
The channel regions 215, 225 shown in
According to exemplary embodiments, the above-described functionalization of the membrane 120 takes place (for example during the production step from
The exemplary embodiment in
As described with
In addition, the first electrode 315 and the second electrode 325 are formed on the substrate 610a of the first detector section 210 (see
The exemplary embodiment of
Thus, in the exemplary embodiment in
Advantageous aspects of exemplary embodiments of the present invention relate in particular to the following:
Functionalization after chip production has the following advantages over pre-functionalized pores:
Exemplary embodiments also offer the following advantages:
A channel width of 50 microns can be used, which corresponds to a wetting area of 2,500 μm2. The wetting area can be further reduced to 100 μm2. In conventional processes, only a wetting area of 31,416 μm2 has been achieved.
The functional principle described so far is based on a voltametric method. Other measuring principles are used in further exemplary embodiments. These are for example:
(i) Flow measurement through the pore 110;
(ii) Impedance measurements; and
(iii) Electrokinetic measurements (electrophoresis, electroosmosis, etc.).
Ultimately, however, these measuring principles also measure a resistance which impedes the flow of the biomolecules 114 through the pore 110. Only the measured variable changes: in (i) the flow velocity of the medium 50; in (ii) an electrical impedance; in (iii) an electrokinematic quantity.
In comparison to current methods, which detect the respective analyte/ligand molecules in a complex manner, exemplary embodiments of the present invention enable a concentration measurement with higher selectivity and sensitivity compared to the analysis methods currently available. Different ligands in biotic and abiotic systems can be detected with this. These include the following groups of organisms and their components:
Low molecular weight organic and inorganic compounds of any kind
Environmental toxins
Agrochemicals
Hormones
Proteins
Antibiotics
Neurotoxins
Bacteria
Viruses
Parasites
The integration of the nanosensors into a mass-producible lab-on-chip system is made possible by this invention, which can be used as a compact, portable analysis system for the above-mentioned applications. This enables the measurement to be carried out within a few minutes, which can be life-saving in selected cases. The detection system can be used as a single-use microfluidic system so that it is used once for each individual test. The system can therefore be produced in large numbers.
The features of the invention disclosed in the description, the claims and the figures may be essential for the realization of the invention either individually or in any combination.
Although the invention has been illustrated and described in detail by way of preferred embodiments, the invention is not limited by the examples disclosed, and other variations can be derived from these by the person skilled in the art without leaving the scope of the invention. It is therefore clear that there is a plurality of possible variations. It is also clear that embodiments stated by way of example are only really examples that are not to be seen as limiting the scope, application possibilities or configuration of the invention in any way. In fact, the preceding description and the description of the figures enable the person skilled in the art to implement the exemplary embodiments in concrete manner, wherein, with the knowledge of the disclosed inventive concept, the person skilled in the art is able to undertake various changes, for example, with regard to the functioning or arrangement of individual elements stated in an exemplary embodiment without leaving the scope of the invention, which is defined by the claims and their legal equivalents, such as further explanations in the description.
Number | Date | Country | Kind |
---|---|---|---|
10 2017 114 349.1 | Jun 2017 | DE | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2018/065542 | 6/12/2018 | WO | 00 |